Chaperone proteins may help lower alpha-synuclein in Parkinson’s

A recent study found that higher levels of proteins called chaperones may help reduce harmful protein clumps linked to Parkinson’s disease in the brain. This suggests that boosting chaperone proteins could be a useful approach for treating the disease. The study also found that inflammation in the brain, or neuroinflammation, may play a major role in Parkinson’s. Researchers studied brain cells from six people who had Parkinson’s and six without, using advanced techniques to examine gene activity and protein levels. They found that people with higher chaperone levels had fewer toxic protein clumps. Chaperones help other proteins keep their proper shape, which could prevent the buildup of damaging clumps in the brain. The study also noted that people with Parkinson’s have more inflammatory immune cells, pointing to inflammation as a potential cause rather than just a result of the disease. This suggests that targeting inflammation might be an effective treatment strategy. Comparing their findings to similar research on Alzheimer’s disease, the researchers saw that, while both diseases involve inflammation, the specific brain cell changes are distinct. This highlights the need for unique treatments for each condition.